Provide Pre-approval Single-patient Expanded Access (Compassionate Use) of VYD222 for Patients With Symptomatic COVID-19 Refractory to Other Treatments

Invivyd

Status

Conditions: COVID-19

Treatments: Drug: VYD222

Study type: Expanded Access

Funder types: Industry; Other

Identifiers

NCT06004128

VYD222-EA-001

Details and patient eligibility

About

Provide pre-approval single-patient Expanded Access (Compassionate Use) of VYD222 for patients with symptomatic COVID-19 refractory to other treatments.

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria